GRAY Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-14 | BREUIL ROBERT S | officer: Chief Financial Officer | 30,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
2023-03-14 | BREUIL ROBERT S | officer: Chief Financial Officer | 162,119 | F-InKind | D | 1,730 | 0.58 | 1,003.40 |
2023-03-14 | BREUIL ROBERT S | officer: Chief Financial Officer | 163,849 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
2023-03-03 | Zamiri Parisa | officer: Chief Medical Officer | 393,750 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2023-03-03 | Zamiri Parisa | officer: Chief Medical Officer | 0 | M-Exempt | D | 83,155 | 0.00 | 0.00 |
2023-03-03 | Zamiri Parisa | officer: Chief Medical Officer | 84,375 | M-Exempt | D | 9,375 | 0.00 | 0.00 |
2023-03-03 | Zamiri Parisa | officer: Chief Medical Officer | 135,338 | F-InKind | D | 42,894 | 0.57 | 24,449.58 |
2023-03-03 | Zamiri Parisa | officer: Chief Medical Officer | 178,232 | M-Exempt | A | 120,655 | 0.00 | 0.00 |
2023-03-03 | Guerard Frederic | director, officer: Chief Executive Officer | 918,750 | M-Exempt | D | 65,625 | 0.00 | 0.00 |
2023-03-03 | Guerard Frederic | director, officer: Chief Executive Officer | 0 | M-Exempt | D | 221,746 | 0.00 | 0.00 |
2023-03-03 | Guerard Frederic | director, officer: Chief Executive Officer | 253,125 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2023-03-03 | Guerard Frederic | director, officer: Chief Executive Officer | 383,682 | F-InKind | D | 89,344 | 0.57 | 50,926.08 |
2023-03-03 | Guerard Frederic | director, officer: Chief Executive Officer | 473,026 | M-Exempt | A | 315,496 | 0.00 | 0.00 |
2023-03-03 | BREUIL ROBERT S | officer: Chief Financial Officer | 393,750 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2023-03-03 | BREUIL ROBERT S | officer: Chief Financial Officer | 0 | M-Exempt | D | 83,155 | 0.00 | 0.00 |
2023-03-03 | BREUIL ROBERT S | officer: Chief Financial Officer | 89,438 | M-Exempt | D | 9,937 | 0.00 | 0.00 |
2023-03-03 | BREUIL ROBERT S | officer: Chief Financial Officer | 158,849 | F-InKind | D | 49,434 | 0.57 | 28,177.38 |
2023-03-03 | BREUIL ROBERT S | officer: Chief Financial Officer | 208,283 | M-Exempt | A | 121,217 | 0.00 | 0.00 |
2022-12-12 | BREUIL ROBERT S | officer: Chief Financial Officer | 35,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
2022-12-12 | BREUIL ROBERT S | officer: Chief Financial Officer | 87,066 | F-InKind | D | 1,729 | 0.58 | 1,002.82 |
2022-12-12 | BREUIL ROBERT S | officer: Chief Financial Officer | 88,795 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
2022-12-01 | Guerard Frederic | director, officer: Chief Executive Officer | 281,250 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2022-12-01 | Guerard Frederic | director, officer: Chief Executive Officer | 157,530 | F-InKind | D | 11,068 | 0.63 | 6,972.84 |
2022-12-01 | Guerard Frederic | director, officer: Chief Executive Officer | 168,598 | M-Exempt | A | 28,125 | 0.00 | 0.00 |
2022-12-01 | Zamiri Parisa | officer: Chief Medical Officer | 93,750 | M-Exempt | D | 9,375 | 0.00 | 0.00 |
2022-12-01 | Zamiri Parisa | officer: Chief Medical Officer | 57,577 | F-InKind | D | 2,752 | 0.63 | 1,733.76 |
2022-12-01 | Zamiri Parisa | officer: Chief Medical Officer | 60,329 | M-Exempt | A | 9,375 | 0.00 | 0.00 |
2022-12-01 | BREUIL ROBERT S | officer: Chief Financial Officer | 99,375 | M-Exempt | D | 9,938 | 0.00 | 0.00 |
2022-12-01 | BREUIL ROBERT S | officer: Chief Financial Officer | 83,795 | F-InKind | D | 3,437 | 0.63 | 2,165.31 |
2022-12-01 | BREUIL ROBERT S | officer: Chief Financial Officer | 87,232 | M-Exempt | A | 9,938 | 0.00 | 0.00 |
2022-11-24 | Guerard Frederic | director, officer: Chief Executive Officer | 984,375 | M-Exempt | D | 65,625 | 0.00 | 0.00 |
2022-11-24 | Guerard Frederic | director, officer: Chief Executive Officer | 140,473 | F-InKind | D | 25,824 | 0.67 | 17,302.08 |
2022-11-24 | Guerard Frederic | director, officer: Chief Executive Officer | 166,297 | M-Exempt | A | 65,625 | 0.00 | 0.00 |
2022-11-24 | Zamiri Parisa | officer: Chief Medical Officer | 421,875 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2022-11-24 | Zamiri Parisa | officer: Chief Medical Officer | 50,954 | F-InKind | D | 8,255 | 0.67 | 5,530.85 |
2022-11-24 | Zamiri Parisa | officer: Chief Medical Officer | 59,209 | M-Exempt | A | 28,125 | 0.00 | 0.00 |
2022-11-24 | BREUIL ROBERT S | officer: Chief Financial Officer | 421,875 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2022-11-24 | BREUIL ROBERT S | officer: Chief Financial Officer | 77,294 | F-InKind | D | 9,726 | 0.67 | 6,516.42 |
2022-11-24 | BREUIL ROBERT S | officer: Chief Financial Officer | 87,020 | M-Exempt | A | 28,125 | 0.00 | 0.00 |
2022-09-23 | BREUIL ROBERT S | officer: Chief Financial Officer | 58,895 | F-InKind | D | 1,684 | 0.97 | 1,626.91 |
2022-09-04 | BREUIL ROBERT S | officer: Chief Financial Officer | 40,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
2022-09-04 | BREUIL ROBERT S | officer: Chief Financial Officer | 60,579 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
2022-08-24 | BREUIL ROBERT S | officer: Chief Financial Officer | 450,000 | A-Award | A | 450,000 | 0.00 | 0.00 |
2022-08-24 | Guerard Frederic | director, officer: Chief Executive Officer | 1,050,000 | A-Award | A | 1,050,000 | 0.00 | 0.00 |
2022-08-24 | Zamiri Parisa | officer: Chief Medical Officer | 450,000 | A-Award | A | 450,000 | 0.00 | 0.00 |
2022-08-19 | Guerard Frederic | director, officer: Chief Executive Officer | 309,375 | M-Exempt | D | 28,125 | 0.00 | 0.00 |
2022-08-19 | Guerard Frederic | director, officer: Chief Executive Officer | 100,672 | F-InKind | D | 6,596 | 0.97 | 6,398.12 |
2022-08-19 | Guerard Frederic | director, officer: Chief Executive Officer | 107,268 | M-Exempt | A | 28,125 | 0.00 | 0.00 |
2022-08-19 | Zamiri Parisa | officer: Chief Medical Officer | 103,125 | M-Exempt | D | 9,375 | 0.00 | 0.00 |
2022-08-19 | Zamiri Parisa | officer: Chief Medical Officer | 31,084 | F-InKind | D | 2,668 | 0.97 | 2,587.96 |
2022-08-19 | Zamiri Parisa | officer: Chief Medical Officer | 33,752 | M-Exempt | A | 9,375 | 0.00 | 0.00 |
2022-08-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 109,313 | M-Exempt | D | 9,937 | 0.00 | 0.00 |
2022-08-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 55,579 | F-InKind | D | 3,347 | 0.97 | 3,246.59 |
2022-08-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 58,926 | M-Exempt | A | 9,937 | 0.00 | 0.00 |
2022-06-09 | BREUIL ROBERT S | officer: Chief Financial Officer | 45,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
2022-06-09 | BREUIL ROBERT S | officer: Chief Financial Officer | 48,989 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
2022-06-02 | SHAFFER CHRISTY L | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | SHAFFER CHRISTY L | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | EASTLAND JULIA MARIE | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | EASTLAND JULIA MARIE | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | Sauer Dirk | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | Sauer Dirk | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | ACKERMANN CHRISTINA | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | ACKERMANN CHRISTINA | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | BJERKHOLT ERIC | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-06-02 | BJERKHOLT ERIC | director | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2022-05-19 | Guerard Frederic | director, officer: Chief Executive Officer | 337,500 | M-Exempt | D | 112,500 | 0.00 | 0.00 |
2022-05-19 | Guerard Frederic | director, officer: Chief Executive Officer | 79,143 | F-InKind | D | 33,357 | 0.90 | 30,057.99 |
2022-05-19 | Guerard Frederic | director, officer: Chief Executive Officer | 112,500 | M-Exempt | A | 112,500 | 0.00 | 0.00 |
2022-05-19 | Zamiri Parisa | officer: Chief Medical Officer | 112,500 | M-Exempt | D | 37,500 | 0.00 | 0.00 |
2022-05-19 | Zamiri Parisa | officer: Chief Medical Officer | 24,377 | F-InKind | D | 13,123 | 0.90 | 11,825.14 |
2022-05-19 | Zamiri Parisa | officer: Chief Medical Officer | 37,500 | M-Exempt | A | 37,500 | 0.00 | 0.00 |
2022-05-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 119,250 | M-Exempt | D | 39,750 | 0.00 | 0.00 |
2022-05-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 43,989 | F-InKind | D | 16,290 | 0.90 | 14,678.92 |
2022-05-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 60,279 | M-Exempt | A | 39,750 | 0.00 | 0.00 |
2022-04-13 | Sauer Dirk | director | 80,000 | A-Award | A | 80,000 | 1.22 | 97,600.00 |
2022-03-31 | BREUIL ROBERT S | officer: Chief Financial Officer | 50,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
2022-03-31 | BREUIL ROBERT S | officer: Chief Financial Officer | 20,529 | S-Sale | D | 2,188 | 1.25 | 2,735.00 |
2022-03-31 | BREUIL ROBERT S | officer: Chief Financial Officer | 22,717 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
2022-02-28 | Zamiri Parisa | officer: Chief Medical Officer | 83,155 | A-Award | A | 83,155 | 0.00 | 0.00 |
2022-02-28 | Zamiri Parisa | officer: Chief Medical Officer | 63,845 | A-Award | A | 63,845 | 1.33 | 84,913.85 |
2022-02-28 | BREUIL ROBERT S | officer: Chief Financial Officer | 83,155 | A-Award | A | 83,155 | 0.00 | 0.00 |
2022-02-28 | BREUIL ROBERT S | officer: Chief Financial Officer | 63,845 | A-Award | A | 63,845 | 1.33 | 84,913.85 |
2022-02-28 | Guerard Frederic | director, officer: Chief Executive Officer | 221,746 | A-Award | A | 221,746 | 0.00 | 0.00 |
2022-02-28 | Guerard Frederic | director, officer: Chief Executive Officer | 170,054 | A-Award | A | 170,054 | 1.33 | 226,171.82 |
2021-12-04 | BREUIL ROBERT S | officer: Chief Financial Officer | 55,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
2021-12-04 | BREUIL ROBERT S | officer: Chief Financial Officer | 17,717 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
2021-09-22 | BREUIL ROBERT S | officer: Chief Financial Officer | 60,000 | M-Exempt | D | 20,000 | 0.00 | 0.00 |
2021-09-22 | BREUIL ROBERT S | officer: Chief Financial Officer | 12,717 | S-Sale | D | 7,283 | 3.55 | 25,853.92 |
2021-09-22 | BREUIL ROBERT S | officer: Chief Financial Officer | 20,000 | M-Exempt | A | 20,000 | 0.00 | 0.00 |
2021-06-02 | ACKERMANN CHRISTINA | director | 12,500 | A-Award | A | 12,500 | 4.07 | 50,875.00 |
2021-06-02 | SHAFFER CHRISTY L | director | 12,500 | A-Award | A | 12,500 | 0.00 | 0.00 |
2021-06-02 | BJERKHOLT ERIC | director | 12,500 | A-Award | A | 12,500 | 4.07 | 50,875.00 |
2021-06-02 | EASTLAND JULIA MARIE | director | 12,500 | A-Award | A | 12,500 | 0.00 | 0.00 |
2021-06-02 | Cagle Gerald D. | director | 12,500 | A-Award | A | 12,500 | 0.00 | 0.00 |
2021-05-19 | Guerard Frederic | director, officer: Chief Executive Officer | 660,000 | A-Award | A | 660,000 | 3.73 | 2,461,800.00 |
2021-05-19 | Guerard Frederic | director, officer: Chief Executive Officer | 450,000 | A-Award | A | 450,000 | 0.00 | 0.00 |
2021-05-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 232,000 | A-Award | A | 232,000 | 0.00 | 0.00 |
2021-05-19 | BREUIL ROBERT S | officer: Chief Financial Officer | 159,000 | A-Award | A | 159,000 | 0.00 | 0.00 |
2021-05-19 | Zamiri Parisa | officer: Chief Medical Officer | 150,000 | A-Award | A | 150,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.